Body Fluids

Clinical laboratory technologists know they can rely on a control manufactured by Streck. This reputation for excellence is the driving force behind Streck’s body fluid control products, including manual and automated body fluid controls and sperm count controls.

Streck customers also have access to STATS®, a free interlaboratory quality control program with peer group data comparison and online submission.

Sperm-Chex control

Cell-Chex® multi-level manual cerebrospinal and body fluid control

Cell-Chex®

Cell-Chex is a multi-level manual cerebrospinal and body fluid control for evaluating the accuracy and precision of hemacytometer RBC and WBC counts, urate and CPPD crystal identification …

Cell-Chex® multi-level manual cerebrospinal and body fluid control

Cell-Chex® Auto

Cell-Chex Auto is an automated body fluid cell count control for Abbott, Beckman Coulter, Siemens Healthcare Diagnostics and Sysmex hematology analyzers. The tri-level control verifies instrument …

Sperm-Chex manual sperm count control

Sperm-Chex®

Sperm-Chex is an FDA-cleared manual sperm count control that contains real stabilized sperm cells, not latex beads. The manual sperm count control can be handled like a patient sample …

Sperm-Chex Post VC post vasectomy sperm count control

Sperm-Chex® Post VC

Sperm-Chex Post VC is an FDA-cleared post-vasectomy sperm count control that contains real stabilized sperm cells, not latex beads. The manual sperm count control can be handled like …

The latest from the blog

Molecular

Wastewater testing for AR

The use of wastewater epidemiology has become, in a few short years, a powerful tool in tracking the spread of SARS-CoV-2 in communities and has facil…
Read More
Wastewater Based Epidemiology
Molecular

WBE critical COVID tracking tool

Wastewater Based Epidemiology (WBE) has become an important tool for tracking the level of SARS-CoV-2 viral load in communities, but inconsistent fund…
Read More
Sequencing DNA
Stabilization

FDA drafts guidance on ctDNA

Earlier this year, the U.S. Food and Drug Administration released a draft guidance regarding the use of circulating tumor DNA (ctDNA) for early-stage …
Read More